Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | M032 |
| Trade Name | |
| Synonyms | M 032|M-032|NSC 733972 |
| Drug Descriptions |
M032 is an oncolytic herpes simplex virus-1 (HSV-1) engineered to express IL-12, which may result in increased anti-tumor immune response and decreased tumor cells proliferation (PMID: 33524948; NCI Drug Dictionary). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C114294 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| M032 | M032 | 0 | 2 |
| M032 + Pembrolizumab | M032 Pembrolizumab | 0 | 1 |